Venture capital firm V-Bio Ventures has reached the final close of its second fund, with Vanden Avenue Commodities among the limited partners.
V-Bio Ventures, the Belgium-based venture capital firm aligned with research institute VIB, closed its second fund at €110m ($122m) today with backing from agricultural product trader Vanden Avenue Commodities.
The firm did not identify any new limited partners but Vanden Avenue was one of the LPs in the fund’s €96m second close, disclosed in January this year. V-Bio Fund 2 exceeded its €100m target.
VIB, KU Leuven, Ghent University, European Investment Fund, ParticipatieMaatschappij Vlaanderen, Federale Participatie- en Investeringsmaatschappij, BNP Paribas…
